104 Boulevard du Montparnasse, 75014 PARIS
+33 (0)1 56 88 11 88

Half Year 2017 Earnings

Half Year 2017 Earnings

Thomas Lingelbach
President & CEO

Paris, August 31, 2017 – Valneva, a leading European biotech company specialized in innovative vaccines, reports earnings for the first half of 2017. Thomas Lingelbach, President & CEO of Valneva, comments on the results and the Group’s evolution.
– Company website: www.valneva.com

 

 

More Valneva videos

Group strategy
Thomas Lingelbach
Logo
Half Year 2017 Earnings
Thomas Lingelbach
Logo
Valneva corporate film
Logo
Group strategy
Thomas Lingelbach
Logo